Factors that increase risk for poor adherence to phenylketonuria treatment in Brazilian patients
- 25 March 2021
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (7) , 1991-2002
Abstract
Neurotoxic effects caused by high phenylalanine (Phe) in patients with phenylketonuria (PKU) can be avoided through dietary treatment. However, achieving the recommended Phe levels has been a challenge. This study aimed to investigate factors associated with adherence to PKU treatment among patients followed at a medical genetics public service in southern Brazil. Twenty‐nine patients (early diagnosed, n = 20; late‐diagnosed, n = 9) with classical (n = 16) or mild PKU (n = 13) aged 6–34 years (16.4 ± 7.5) and 16 caregivers were included. Blood Phe levels were recorded, and assessment tools measuring barriers to treatment, IQ, knowledge about disease, treatment, and perceived adherence were collected. Classical PKU patients showed higher current blood Phe levels than mild PKU patients (U = 37.000, p = 0.003). Lifetime and childhood Phe levels were associated with recent metabolic control (τ = 0.76, p = 0.000; τ = 0.70, p = 0.000, respectively). The perception of barriers to treatment was associated with a higher blood Phe level (τ = 0.39, p = 0.003). Tolerance to Phe, metabolic control throughout childhood, and perceived difficulty in living with demands of treatment are important factors of greater vulnerability to poor adherence in PKU patients.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (302850/2017‐1)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001)
This publication has 54 references indexed in Scilit:
- Correlation of age‐specific phenylalanine levels with intellectual outcome in patients with phenylketonuriaJournal of Inherited Metabolic Disease, 2011
- Retrospective, observational data collection of the treatment of phenylketonuria in the UK, and associated clinical and health outcomesCurrent Medical Research and Opinion, 2011
- Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficienciesMolecular Genetics and Metabolism, 2011
- Blood phenylalanine control in phenylketonuria: a survey of 10 European centresEuropean Journal of Clinical Nutrition, 2010
- PhenylketonuriaThe Lancet, 2010
- Socioeconomic status and the brain: mechanistic insights from human and animal researchNature Reviews Neuroscience, 2010
- Home literacy predictors of early reading development in children with cerebral palsyResearch in Developmental Disabilities, 2009
- Determinants of cognitive function in childhood: A cohort study in a middle income contextBMC Public Health, 2008
- Living with phenylketonuria: Perspectives of patients and their familiesJournal of Inherited Metabolic Disease, 2004
- Importância do diagnóstico e tratamento da fenilcetonúriaRevista de Saúde Pública, 2000